Skip to content

The efficacy of hydrogen gas inhalation during Perctaneous Coronary Intervention in patients with ST elevation acute myocardial infarction

The efficacy of hydrogen gas inhalation during Perctaneous Coronary Intervention in patients with ST elevation acute myocardial infarction - The efficacy of hydrogen gas Inhalation in patients with ST elevation acute myocardial infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014390
Enrollment
50
Registered
2014-07-01
Start date
2013-05-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

Patients who diagnose that they are having an acute myocardial infarction at a cardiovascular angiogram room start to inhale gas and continue to inhale gas during PCI procedure. Control group: contro

Sponsors

National Center for Global Health and Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ST-segment elevation myocardial infarction within 12hours following the onset of chest pain

Exclusion criteria

Exclusion criteria: Shock (BP<90mmHg) Patient of Congestive Heart Failure or Severe hypoxia (SpO2<94% using nasal 4l O2 inhale) Sustained VT or VF Post-cardiopulmonary resuscitation Patients with absolute contraindications to MRI scans The patient who is not provided of the written agreement. The patient who judged a trial entry doctor to be inappropriate as an object of the final examination.

Design outcomes

Primary

MeasureTime frame
Evaluation of the extent of myocardial ischemia-reperfusion injury by cardiovascular magnetic resonance imaging 30 days after acute myocardial infarction

Secondary

MeasureTime frame
Angiographic assessment of reperfision by TIMI flow grade and myocardial blush grade. Assessment of reperfusion by ST resolution comparison of prePCI and post PCI. Assessment of infarct size by creatine phosphokinase (CPK). Assessment of left ventricular failure by Killip classification. Evaluation of left ventricular ejection fraction and infarct size by cardiac MRI imaging in chronic phase. Assesment of major advance cardiac event.

Countries

Japan

Contacts

Public ContactHisao Hara

National Center for Global Health and Medicine Department of Cardiology

hhara@hosp.ncgm.go.jp03-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026